Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer

18 Oct 2022

Abstract excerpt

Prostate cancer (PCa) is a common malignant disease among men and biochemical recurrence (BCR) is considered to be a decisive risk factor for clinical recurrence and PCa metastasis. Clarifying the genes related to BCR and its possible pathways is vital for providing diagnosis and treatment methods to delay the progress of BCR. An analysis of data concerning PCa from previous datasets of The Cancer Genome Atlas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Prostate Cancer Treatment and Research
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36257969
DOI: 10.1038/s41598-022-20775-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancerPMID 36257969Read ↗

A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA databaseSemantic proximity Read ↗

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read ↗

Comprehensive multi-omics analysis reveals the molecular mechanism of prostate cancer recurrenceSemantic proximity Read ↗

A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer.Semantic proximity Read ↗

TOP2A and PPARGC1A differentiate chromatin regulator-related subtypes for prostate cancer patients undergoing radical prostatectomySemantic proximity Read ↗

Identification and validation of a prognostic 5-protein signature for biochemical recurrence following radical prostatectomy in prostate cancerSemantic proximity Read ↗

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate CancerSemantic proximity Read ↗

Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progressionSemantic proximity Read ↗

A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer PatientsSemantic proximity Read ↗

ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancerSemantic proximity Read ↗

Prediction of metastatic and recurrence in prostate cancer patients based on BMP-related differential gene indicators in prostate cancer bone metastasesSemantic proximity Read ↗

Development of a biochemical recurrence prediction model based on pyroptosis related genes in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.